Zizheng Dong

Effective Targeting of the Survivin Dimerization Interface with Small-Molecule Inhibitors.

Jing Qi, Jian-Ting Zhang, Shaobo Zhang, 2016, Cancer research.

Modulation of Differentiation-related Gene 1 Expression by Cell Cycle Blocker Mimosine, Revealed by Proteomic Analysis*

Yehia Mechref, Randy J Arnold, Milos V Novotny, 2005, Molecular & Cellular Proteomics.

Regulation of expression by promoters versus internal ribosome entry site in the 5′-untranslated sequence of the human cyclin-dependent kinase inhibitor p27kip1

Yang Liu, Baoguang Han, Yang Liu, 2005, Nucleic acids research.

Role of 14-3-3σ in poor prognosis and in radiation and drug resistance of human pancreatic cancers

Jian-Ting Zhang, Zizheng Dong, Zhaomin Li, 2010, BMC Cancer.

Tight Control of Platelet-derived Growth Factor B/c-sis Expression by Interplay between the 5′-Untranslated Region Sequence and the Major Upstream Promoter*

Baoguang Han, Jian-Ting Zhang, Zizheng Dong, 2003, Journal of Biological Chemistry.

EIF3 p170, a mediator of mimosine effect on protein synthesis and cell cycle progression.

Jian-Ting Zhang, Zizheng Dong, Jian-Ting Zhang, 2003, Molecular biology of the cell.

Differential response to doxorubicin in breast cancer subtypes simulated by a microfluidic tumor model

Ick Chan Kwon, Kinam Park, Bumsoo Han, 2017, Journal of controlled release : official journal of the Controlled Release Society.

Oligomerization domain of the multidrug resistance-associated transporter ABCG2 and its dominant inhibitory activity.

Hui Peng, Yang Liu, Junkang Xu, 2007, Cancer research.